Global Hair Loss Treatment Products Market
Market Size in USD Billion
CAGR :
%
USD
2.49 Billion
USD
3.57 Billion
2024
2032
| 2025 –2032 | |
| USD 2.49 Billion | |
| USD 3.57 Billion | |
|
|
|
|
Global Hair Loss Treatment Products Market Segmentation, By Product Type (Shampoos and conditioners, Supplements and Vitamins, Serum and Oil, and Others), Disease Type (Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, and Others), Distribution Channel (Hypermarkets and supermarkets, Medical/pharmacy stores, E-commerce, Departmental Stores, Convenience Stores, and Others), Gender (Male, Female, and Children), End User (Hospitals, Home Healthcare Settings, Dermatology Centres, and Others) – Industry Trends and Forecast to 2032
Hair Loss Treatment Products Market Analysis
The hair loss treatment products market is experiencing robust growth driven by rising awareness about hair care and advancements in treatment solutions. Hair loss, a common issue among men and women, has led to increasing demand for effective treatments ranging from topical products to advanced medical therapies. The market encompasses a wide array of products, including shampoos, conditioners, serums, supplements, and medications, targeting specific hair loss conditions such as alopecia areata, traction alopecia, and androgenic alopecia. Technological advancements have played a pivotal role in transforming the market. Innovations such as laser hair regrowth devices, platelet-rich plasma (PRP) therapy, and products containing bioactive compounds such as minoxidil and finasteride have enhanced treatment efficacy. In addition, the development of plant-based and organic formulations has gained traction, appealing to consumers seeking natural solutions. Regions such as North America and Asia-Pacific are emerging as key markets, with factors such as rising disposable incomes, improved access to healthcare, and increasing awareness of advanced hair loss treatments driving growth. As companies continue to invest in research and development, the market is poised for significant expansion, offering tailored solutions to meet diverse consumer needs.
Hair Loss Treatment Products Market Size
The global hair loss treatment products market size was valued at USD 2.49 billion in 2024 and is projected to reach USD 3.57 billion by 2032, with a CAGR of 4.63% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.
Hair Loss Treatment Products Market Trends
“Adoption of Personalized Hair Care Solutions”
The hair loss treatment products market is witnessing a significant trend toward personalized hair care solutions, driven by advancements in technology and growing consumer demand for tailored treatments. Companies are leveraging AI-based diagnostics and genetic testing to develop customized regimens that address individual hair loss conditions, such as androgenic alopecia or alopecia areata. For instance, brands such as HairMax use AI tools to analyze scalp conditions and recommend laser devices or topical solutions specifically suited to the user’s needs. In addition, personalized subscription services offering curated products, including shampoos, serums, and supplements, have gained popularity among younger, tech-savvy consumers. This shift toward personalization enhances treatment efficacy and improves customer satisfaction and loyalty. With rising awareness about the importance of early intervention and tailored care, the market for customized hair loss treatments is expected to grow, offering innovative solutions to meet diverse consumer demands.
Report Scope and Hair Loss Treatment Products Market Segmentation
|
Attributes |
Hair Loss Treatment Products Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Ales Grup (Turkey), GEROLYMATOS INTERNATIONAL S.A. (Greece), iGrow Laser (U.S.), Curallux, LLC. (U.S.), Coegin Pharma AB (Sweden), HCell Inc. (U.S.), Freedom Laser Therapy, Inc. (U.S.), Taisho Pharmaceutical Holdings Co., Ltd. (Japan), Thymuskin (Germany), Vitabiotics Ltd. (U.K.), Endo, Inc. (U.S.), Teva Pharmaceuticals USA, Inc. (Israel), Pfizer Inc. (U.S.), Par Pharmaceutical (U.S.), GSK plc (U.K.), Dr. Reddy’s Laboratories Ltd. (India), Abbott (U.S.), Zydus Pharmaceuticals, Inc. (India), Johnson & Johnson Services, Inc. (U.S.), Cipla Inc. (India), and Sun Pharmaceutical Industries Ltd. (India) |
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Hair Loss Treatment Products Market Definition
Hair loss treatment products are specialized formulations and solutions designed to address hair thinning, hair fall, and baldness caused by various factors, such as genetic predisposition, hormonal changes, stress, medical conditions, or environmental influences. These products encompass a wide range of categories, including shampoos, conditioners, serums, supplements, and medications, as well as advanced therapies such as laser devices and platelet-rich plasma (PRP).
Hair Loss Treatment Products Market Dynamics
Drivers
- Increasing Prevalence of Hair Loss
The increasing prevalence of hair loss has become a significant market driver, with millions of individuals worldwide seeking effective solutions to address this concern. According to the American Academy of Dermatology, approximately 80 million people in the U.S. alone experience hereditary hair loss, with conditions such as androgenic alopecia affecting both men and women. Beyond genetics, factors such as stress, hormonal imbalances, and aging further contribute to hair thinning and baldness. For instance, studies suggest that nearly 40% of women experience noticeable hair loss by age 50, while stress-induced hair fall, or telogen effluvium, has surged in recent years due to lifestyle pressures. This growing prevalence has increased the demand for advanced treatment options, including topical solutions, oral supplements, and laser therapies, prompting manufacturers to develop innovative products to cater to a wider audience and capitalize on this expanding market.
- Rising Disposable Income
Rising disposable income in developing regions is a key market driver for the hair loss treatment products market, enabling consumers to allocate more resources toward premium and advanced solutions. For instance, data from the World Bank highlights a steady rise in per capita income in countries such as India and China, with India's gross national income per capita reaching $2,388 in 2022, marking significant economic growth. This increased purchasing power has led to a surge in demand for high-quality, specialized hair care products, including serums, supplements, and laser devices. In addition, the growing middle-class population in these regions is becoming more health-conscious and willing to invest in cosmetic and therapeutic solutions for hair loss. For instance, the Indian hair care market, which includes hair loss treatments, is projected to grow at a CAGR of over 6% during the forecast period, reflecting consumers’ shift toward premium and innovative offerings.
Opportunities
- Growing Awareness about Advanced Hair Loss Treatment
Growing awareness about advanced hair loss treatment options is emerging as a significant market opportunity, encouraging consumers to seek early intervention. With increased access to information through digital platforms and social media, individuals are becoming more informed about available treatments, such as topical solutions such as minoxidil, oral supplements containing biotin, and medical therapies such as platelet-rich plasma (PRP). For instance, platforms such as Instagram and YouTube host countless tutorials and testimonials, making treatments more relatable and accessible to a broader audience. In addition, dermatology clinics and online consultation services have made professional advice easier to obtain, particularly in urban areas. Brands such as Viviscal and Nutrafol have capitalized on this trend by offering personalized solutions backed by clinical research, further gaining consumer trust. This rising awareness promotes early adoption of effective treatments and creates room for innovation and market expansion, particularly in underserved regions.
- Increasing Technological Advancements in Hair Loss Treatments
Technological advancements in hair loss treatments, such as laser therapies, PRP treatments, and AI-based personalized solutions, have created a market opportunity by significantly improving the effectiveness of these treatments and boosting consumer trust. For instance, laser devices such as the HairMax LaserComb use low-level laser therapy (LLLT) to stimulate hair follicles and promote hair growth, with clinical studies showing its positive effects. Similarly, PRP (platelet-rich plasma) therapy, where a patient's blood is used to stimulate hair regrowth, has gained popularity due to its non-invasive nature and proven results. The introduction of AI-powered platforms such as Nutrafol's personalized hair health plans uses genetic data and lifestyle factors to create customized hair care regimens, enhancing treatment efficacy and user satisfaction. These technological innovations offer a higher level of precision and personalization, attracting consumers who seek more effective and scientifically-backed solutions, thus driving the growth of the hair loss treatment products market.
Restraints/Challenges
- Side Effects and Safety Concerns
Side effects and safety concerns present a significant challenge in the hair loss treatment products market, as many consumers are hesitant to use products that may cause adverse reactions. For instance, minoxidil, one of the most widely used treatments for hair loss, can cause scalp irritation, dryness, or unwanted facial hair growth in some users. Prescription treatments such as finasteride have been linked to potential side effects such as decreased libido, erectile dysfunction, and mood changes, which can deter consumers from using them, especially given the long-term commitment required for noticeable results. These safety concerns, along with negative publicity from users who experience side effects, can erode consumer confidence in these treatments. As a result, potential users may opt for alternative, less-regulated products or natural remedies, further complicating market growth and acceptance. Manufacturers must ensure that their products are both effective and safe, balancing efficacy with minimal adverse effects to build consumer trust and overcome this market challenge.
- High Product Costs
High product costs are a significant challenge in the hair loss treatment products market, as many of the effective solutions—ranging from prescription medications such as finasteride and minoxidil to advanced treatments such as laser therapy devices—come with a hefty price tag. For instance, a monthly supply of minoxidil, an FDA-approved topical treatment, can be relatively expensive, while more advanced treatments such as hair growth lasers can cost considerably more, especially for home treatment kits. These ongoing expenses often discourage long-term use, particularly for consumers in price-sensitive markets. In addition, the need for consistent, long-term application of most hair loss products further compounds the financial burden, leading many potential users to abandon treatments before seeing the desired results. The high cost of these products limits accessibility and presents a barrier to widespread market adoption, making affordability a critical challenge for both consumers and manufacturers.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Impact and Current Market Scenario of Raw Material Shortage and Shipping Delays
Data Bridge Market Research offers a high-level analysis of the market and delivers information by keeping in account the impact and current market environment of raw material shortage and shipping delays. This translates into assessing strategic possibilities, creating effective action plans, and assisting businesses in making important decisions.
Apart from the standard report, we also offer in-depth analysis of the procurement level from forecasted shipping delays, distributor mapping by region, commodity analysis, production analysis, price mapping trends, sourcing, category performance analysis, supply chain risk management solutions, advanced benchmarking, and other services for procurement and strategic support.
Expected Impact of Economic Slowdown on the Pricing and Availability of Products
When economic activity slows, industries begin to suffer. The forecasted effects of the economic downturn on the pricing and accessibility of the products are taken into account in the market insight reports and intelligence services provided by DBMR. With this, our clients can typically keep one step ahead of their competitors, project their sales and revenue, and estimate their profit and loss expenditures.
Hair Loss Treatment Products Market Scope
The market is segmented on the basis of product type, disease type, distribution channel, gender, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Shampoos and Conditioners
- Supplements and Vitamins
- Serum and Oil
- Others
Disease Type
- Alopecia Areata
- Cicatricial Alopecia
- Traction Alopecia
- Alopecia Totalis
- Alopecia Universalis
- Others
Distribution Channel
- Hypermarkets and Supermarkets
- Medical/Pharmacy Stores
- E-commerce
- Departmental Stores
- Convenience Stores
- Others
Gender
- Male
- Female
- Children
End User
- Hospitals
- Home Healthcare Settings
- Dermatology Centres
- Others
Hair Loss Treatment Products Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, product type, disease type, distribution channel, gender, and end user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the hair loss treatment products market and is expected to maintain this leadership throughout the forecast period, with the U.S. and Canada emerging as key contributors. The region's large and growing population facing hair loss concerns, combined with increasing awareness of available treatments, fuels market demand. In addition, advancements in product offerings and a high adoption rate of both over-the-counter and prescription treatments further support the market's growth. The rising prevalence of hair loss, coupled with a strong focus on cosmetic solutions, ensures that North America remains a critical player in the global market.
Asia-Pacific is projected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth can be attributed to several key factors, including rising personal disposable income, which allows consumers to invest in hair loss treatment products. The region's rapid globalization has also led to greater exposure to innovative solutions and an increasing preference for premium hair care products. In addition, the aging population in countries such as Japan and China is driving demand, as hair loss becomes more prevalent with age. Increased awareness about hair loss treatment options, fueled by both traditional and digital media, is further contributing to market expansion in this dynamic region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Hair Loss Treatment Products Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Hair Loss Treatment Products Market Leaders Operating in the Market Are:
- Ales Grup (Turkey)
- GEROLYMATOS INTERNATIONAL S.A. (Greece)
- iGrow Laser (U.S.)
- Curallux, LLC. (U.S.)
- Coegin Pharma AB (Sweden)
- HCell Inc. (U.S.)
- Freedom Laser Therapy, Inc. (U.S.)
- Taisho Pharmaceutical Holdings Co., Ltd. (Japan)
- Thymuskin (Germany)
- Vitabiotics Ltd. (U.K.)
- Endo, Inc. (U.S.)
- Teva Pharmaceuticals USA, Inc. (Israel)
- Pfizer Inc. (U.S.)
- Par Pharmaceutical (U.S.)
- GSK plc (U.K.)
- Dr. Reddy’s Laboratories Ltd. (India)
- Abbott (U.S.)
- Zydus Pharmaceuticals, Inc. (India)
- Johnson & Johnson Services, Inc. (U.S.)
- Cipla Inc. (India)
- Sun Pharmaceutical Industries Ltd. (India)
Latest Developments in Hair Loss Treatment Products Market
- In September 2023, Alma Lasers partnered with Kate Hudson for the 'Beyond The Trend' Campaign, aiming to showcase its top products, including LMNT, PrimeX, and others
- In March 2023, Viviscal launched a new line of topical hair care products targeted at women's specific hair concerns. The collection included Viviscal Thickening Shampoo, Viviscal Strengthening Conditioner, and Viviscal Thickening Serum
- In October 2022, Dr. Groot, a South Korean hair care brand, introduced a shampoo containing brewer's yeast, claiming to benefit the scalp microbiome and reduce hair loss symptoms
- In August 2022, UNITE Hair debuted the BOOSTA PLUS+ Hair serum, formulated to stimulate hair growth and prevent hair loss by activating stem cells and rejuvenating hair follicles
- In August 2021, Adon Hair Care Clinic launched the Grow-Dense Hair Serum in the Indian market, an innovative product designed for both men and women to address hair loss and promote regrowth
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 SALES VOLUME
2.2.11 EPIDEMIOLOGY MODELLING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.10 ECONOMIC DEVELOPMENT
16. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT TYPE
16.1 OVERVIEW
16.2 ORAL SUPPLEMENTS
16.2.1 PURE BIOTIN SUPPLEMENTS
16.2.1.1. HIGH-POTENCY BIOTIN SUPPLEMENTS
16.2.1.2. TIME-RELEASE BIOTIN SUPPLEMENTS
16.2.1.3. VEGAN AND ORGANIC BIOTIN SUPPLEMENTS
16.2.1.4. LIQUID BIOTIN FORMULATIONS
16.2.1.5. OTHERS
16.2.2 MULTIVITAMIN COMPLEXES CONTAINING BIOTIN
16.2.3 BIOTIN-ENRICHED HAIR CARE PRODUCTS
16.2.3.1. SHAMPOOS
16.2.3.2. CONDITIONERS
16.2.3.3. HAIR OILS
16.2.3.4. SERUMS
16.2.3.5. OTHERS
16.2.4 GUMMIES AND CHEWABLES WITH BIOTIN
16.2.5 BIOTIN-INFUSED FUNCTIONAL BEVERAGES
16.2.6 AMINO ACID COMPLEXES
16.2.7 OMEGA-3 FATTY ACID CAPSULES
16.2.8 COLLAGEN POWDERS
16.2.9 HERBAL SUPPLEMENTS
16.2.10 OTHERS
16.3 TOPICAL TREATMENTS
16.3.1 HAIR LOSS SHAMPOOS
16.3.2 CONDITIONERS WITH KERATIN AND BIOTIN
16.3.3 SERUMS (MINOXIDIL, BIOTIN-ENRICHED)
16.3.4 HAIR OILS (ARGAN OIL, CASTOR OIL, ONION OIL)
16.3.5 SCALP MASKS AND SCRUBS
16.4 PHARMACEUTICAL SOLUTIONS
16.4.1 MINOXIDIL (ROGAINE)
16.4.2 FINASTERIDE (PROPECIA)
16.4.3 DUTASTERIDE
16.4.4 ANTI-DHT TOPICAL FORMULATIONS
16.5 OTHERS
17. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT FORM
17.1 OVERVIEW
17.2 TABLETS
17.3 CAPSULES
17.4 GUMMIES
17.5 POWDERS
17.6 LIQUID DROPS
17.7 SPRAYS
17.8 OTHER
18. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY APPLICATION TYPE
18.1 OVERVIEW
18.2 ALOPECIA AREATA
18.3 MALE PATTERN BALDNESS
18.4 FEMALE PATTERN HAIR LOSS
18.5 POSTPARTUM HAIR LOSS
18.6 HAIR THINNING DUE TO STRESS
18.7 OTHERS
19. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRICE RANGE
19.1 OVERVIEW
19.2 ENTRY-LEVEL (MASS MARKET)
19.3 MID-RANGE PRODUCTS
19.4 PREMIUM PRODUCTS
20. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDER
20.3 RETAILS
20.3.1 ONLINE
20.3.2 OFFLINE
21. GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION
21.1 GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
21.1.1 NORTH AMERICA
21.1.1.1. U.S.
21.1.1.2. CANADA
21.1.1.3. MEXICO
21.1.2 EUROPE
21.1.2.1. GERMANY
21.1.2.2. FRANCE
21.1.2.3. U.K.
21.1.2.4. HUNGARY
21.1.2.5. LITHUANIA
21.1.2.6. AUSTRIA
21.1.2.7. IRELAND
21.1.2.8. NORWAY
21.1.2.9. POLAND
21.1.2.10. ITALY
21.1.2.11. SPAIN
21.1.2.12. RUSSIA
21.1.2.13. TURKEY
21.1.2.14. NETHERLANDS
21.1.2.15. SWITZERLAND
21.1.2.16. REST OF EUROPE
21.1.3 ASIA-PACIFIC
21.1.3.1. JAPAN
21.1.3.2. CHINA
21.1.3.3. SOUTH KOREA
21.1.3.4. INDIA
21.1.3.5. AUSTRALIA
21.1.3.6. SINGAPORE
21.1.3.7. THAILAND
21.1.3.8. MALAYSIA
21.1.3.9. INDONESIA
21.1.3.10. PHILIPPINES
21.1.3.11. VIETNAM
21.1.3.12. REST OF ASIA-PACIFIC
21.1.4 SOUTH AMERICA
21.1.4.1. BRAZIL
21.1.4.2. ARGENTINA
21.1.4.3. PERU
21.1.4.4. REST OF SOUTH AMERICA
21.1.5 MIDDLE EAST AND AFRICA
21.1.5.1. SOUTH AFRICA
21.1.5.2. SAUDI ARABIA
21.1.5.3. UAE
21.1.5.4. EGYPT
21.1.5.5. KUWAIT
21.1.5.6. ISRAEL
21.1.5.7. REST OF MIDDLE EAST AND AFRICA
21.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
22. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, SWOT AND DBMR ANALYSIS
23. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.2 MERGERS & ACQUISITIONS
23.3 NEW PRODUCT DEVELOPMENT & APPROVALS
23.4 EXPANSIONS
23.5 REGULATORY CHANGES
23.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY PROFILE
24.1 CIPLA
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPEMENTS
24.2 VIVISCAL
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPEMENTS
24.3 PFIZER INC.
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPEMENTS
24.4 DR. REDDY’S LABORATORIES LTD.
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPEMENTS
24.5 REGAINE
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPEMENTS
24.6 CONCERT PHARMACEUTICALS
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPEMENTS
24.7 MERCK & CO., INC
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPEMENTS
24.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPEMENTS
24.9 ABBOTT
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPEMENTS
24.10 ALES GROUP SINGAPORE PTE. LTD
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPEMENTS
24.11 COSTCO WHOLESALE CORPORATION (KIRKLAND SUGNATURE)
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPEMENTS
24.12 JOHNSON & JOHNSON CONSUMER INC.
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPEMENTS
24.13 VITABIOTICS LTD.
24.13.1 COMPANY OVERVIEW
24.13.2 REVENUE ANALYSIS
24.13.3 GEOGRAPHIC PRESENCE
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPEMENTS
24.14 NANOGEN
24.14.1 COMPANY OVERVIEW
24.14.2 REVENUE ANALYSIS
24.14.3 GEOGRAPHIC PRESENCE
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPEMENTS
24.15 DR. KURT WOLFF GMBH & CO. KG
24.15.1 COMPANY OVERVIEW
24.15.2 REVENUE ANALYSIS
24.15.3 GEOGRAPHIC PRESENCE
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPEMENTS
24.16 HISTOGEN INC
24.16.1 COMPANY OVERVIEW
24.16.2 REVENUE ANALYSIS
24.16.3 GEOGRAPHIC PRESENCE
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPEMENTS
24.17 ACLARIS THERAPEUTICS, INC.
24.17.1 COMPANY OVERVIEW
24.17.2 REVENUE ANALYSIS
24.17.3 GEOGRAPHIC PRESENCE
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPEMENTS
24.18 HCELL INC.
24.18.1 COMPANY OVERVIEW
24.18.2 REVENUE ANALYSIS
24.18.3 GEOGRAPHIC PRESENCE
24.18.4 PRODUCT PORTFOLIO
24.18.5 RECENT DEVELOPEMENTS
24.19 GLAXOSMITHKLINE
24.19.1 COMPANY OVERVIEW
24.19.2 REVENUE ANALYSIS
24.19.3 GEOGRAPHIC PRESENCE
24.19.4 PRODUCT PORTFOLIO
24.19.5 RECENT DEVELOPMENTS
24.20 PERRIGO COMPANY PLC
24.20.1 COMPANY OVERVIEW
24.20.2 REVENUE ANALYSIS
24.20.3 GEOGRAPHIC PRESENCE
24.20.4 PRODUCT PORTFOLIO
24.20.5 RECENT DEVELOPEMENTS
24.21 ALLERGAN
24.21.1 COMPANY OVERVIEW
24.21.2 REVENUE ANALYSIS
24.21.3 GEOGRAPHIC PRESENCE
24.21.4 PRODUCT PORTFOLIO
24.21.5 RECENT DEVELOPMENTS
24.22 CASSIOPEA, INC.
24.22.1 COMPANY OVERVIEW
24.22.2 REVENUE ANALYSIS
24.22.3 GEOGRAPHIC PRESENCE
24.22.4 PRODUCT PORTFOLIO
24.22.5 RECENT DEVELOPEMENTS
24.23 HISTOGEN INC.
24.23.1 COMPANY OVERVIEW
24.23.2 REVENUE ANALYSIS
24.23.3 GEOGRAPHIC PRESENCE
24.23.4 PRODUCT PORTFOLIO
24.23.5 RECENT DEVELOPEMENTS
24.24 FOLLICUM AB
24.24.1 COMPANY OVERVIEW
24.24.2 REVENUE ANALYSIS
24.24.3 GEOGRAPHIC PRESENCE
24.24.4 PRODUCT PORTFOLIO
24.24.5 RECENT DEVELOPEMENTS
24.25 LEXINGTON INTL., LLC.
24.25.1 COMPANY OVERVIEW
24.25.2 REVENUE ANALYSIS
24.25.3 GEOGRAPHIC PRESENCE
24.25.4 PRODUCT PORTFOLIO
24.25.5 RECENT DEVELOPMENTS
24.26 PURETECH
24.26.1 COMPANY OVERVIEW
24.26.2 REVENUE ANALYSIS
24.26.3 GEOGRAPHIC PRESENCE
24.26.4 PRODUCT PORTFOLIO
24.26.5 RECENT DEVELOPEMENTS
24.27 AMOREPACIFIC CORPORATION
24.27.1 COMPANY OVERVIEW
24.27.2 REVENUE ANALYSIS
24.27.3 GEOGRAPHIC PRESENCE
24.27.4 PRODUCT PORTFOLIO
24.27.5 RECENT DEVELOPMENTS
24.28 LG HOUSEHOLD & HEALTH CARE
24.28.1 COMPANY OVERVIEW
24.28.2 REVENUE ANALYSIS
24.28.3 GEOGRAPHIC PRESENCE
24.28.4 PRODUCT PORTFOLIO
24.28.5 RECENT DEVELOPMENTS
24.29 KERASYS
24.29.1 COMPANY OVERVIEW
24.29.2 REVENUE ANALYSIS
24.29.3 GEOGRAPHIC PRESENCE
24.29.4 PRODUCT PORTFOLIO
24.29.5 RECENT DEVELOPMENTS
24.30 MEDIHEAL
24.30.1 COMPANY OVERVIEW
24.30.2 REVENUE ANALYSIS
24.30.3 GEOGRAPHIC PRESENCE
24.30.4 PRODUCT PORTFOLIO
24.30.5 RECENT DEVELOPMENTS
24.31 TONYMOLY
24.31.1 COMPANY OVERVIEW
24.31.2 REVENUE ANALYSIS
24.31.3 GEOGRAPHIC PRESENCE
24.31.4 PRODUCT PORTFOLIO
24.31.5 RECENT DEVELOPMENTS
24.32 HANBANG
24.32.1 COMPANY OVERVIEW
24.32.2 REVENUE ANALYSIS
24.32.3 GEOGRAPHIC PRESENCE
24.32.4 PRODUCT PORTFOLIO
24.32.5 RECENT DEVELOPMENTS
24.33 ELISHACOY
24.33.1 COMPANY OVERVIEW
24.33.2 REVENUE ANALYSIS
24.33.3 GEOGRAPHIC PRESENCE
24.33.4 PRODUCT PORTFOLIO
24.33.5 RECENT DEVELOPMENTS
24.34 NATURE REPUBLIC
24.34.1 COMPANY OVERVIEW
24.34.2 REVENUE ANALYSIS
24.34.3 GEOGRAPHIC PRESENCE
24.34.4 PRODUCT PORTFOLIO
24.34.5 RECENT DEVELOPMENTS
24.35 ARIUL
24.35.1 COMPANY OVERVIEW
24.35.2 REVENUE ANALYSIS
24.35.3 GEOGRAPHIC PRESENCE
24.35.4 PRODUCT PORTFOLIO
24.35.5 RECENT DEVELOPMENTS
24.36 AESTHETIC HOUSE
24.36.1 COMPANY OVERVIEW
24.36.2 REVENUE ANALYSIS
24.36.3 GEOGRAPHIC PRESENCE
24.36.4 PRODUCT PORTFOLIO
24.36.5 RECENT DEVELOPMENTS
24.37 DR. FOR HAIR (GLOBALN BIOTECH INC.)
24.37.1 COMPANY OVERVIEW
24.37.2 REVENUE ANALYSIS
24.37.3 GEOGRAPHIC PRESENCE
24.37.4 PRODUCT PORTFOLIO
24.37.5 RECENT DEVELOPMENTS
24.38 INNOHERB
24.38.1 COMPANY OVERVIEW
24.38.2 REVENUE ANALYSIS
24.38.3 GEOGRAPHIC PRESENCE
24.38.4 PRODUCT PORTFOLIO
24.38.5 RECENT DEVELOPMENTS
24.39 LANEIGE
24.39.1 COMPANY OVERVIEW
24.39.2 REVENUE ANALYSIS
24.39.3 GEOGRAPHIC PRESENCE
24.39.4 PRODUCT PORTFOLIO
24.39.5 RECENT DEVELOPMENTS
24.40 HERA
24.40.1 COMPANY OVERVIEW
24.40.2 REVENUE ANALYSIS
24.40.3 GEOGRAPHIC PRESENCE
24.40.4 PRODUCT PORTFOLIO
24.40.5 RECENT DEVELOPMENTS
24.41 COSRX
24.41.1 COMPANY OVERVIEW
24.41.2 REVENUE ANALYSIS
24.41.3 GEOGRAPHIC PRESENCE
24.41.4 PRODUCT PORTFOLIO
24.41.5 RECENT DEVELOPMENTS
24.42 MISSHA
24.42.1 COMPANY OVERVIEW
24.42.2 REVENUE ANALYSIS
24.42.3 GEOGRAPHIC PRESENCE
24.42.4 PRODUCT PORTFOLIO
24.42.5 RECENT DEVELOPMENTS
24.43 SIMPLYO
24.43.1 COMPANY OVERVIEW
24.43.2 REVENUE ANALYSIS
24.43.3 GEOGRAPHIC PRESENCE
24.43.4 PRODUCT PORTFOLIO
24.43.5 RECENT DEVELOPMENTS
24.44 SHISEIDO PROFESSIONAL
24.44.1 COMPANY OVERVIEW
24.44.2 REVENUE ANALYSIS
24.44.3 GEOGRAPHIC PRESENCE
24.44.4 PRODUCT PORTFOLIO
24.44.5 RECENT DEVELOPMENTS
24.45 BIODERMA
24.45.1 COMPANY OVERVIEW
24.45.2 REVENUE ANALYSIS
24.45.3 GEOGRAPHIC PRESENCE
24.45.4 PRODUCT PORTFOLIO
24.45.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
25. RELATED REPORTS
26. QUESTIONNAIRE
27. CONCLUSION
28. ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

